The partnership combines RRG’s FDA-registered, CLIA-certified laboratory and industry-leading biologic products with ...

The Arvix BioMatrix™ platform is a modular biologic system comprising Base™, Core™, and Prime™ components designed to ...

GLP-1 therapies are a cornerstone for the management of type 2 diabetes, supporting glycemic control and improving ...

On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026. The Inflation Reduction Act (IRA), passed in August 2022, gives Medicare ...

USFDA accepts for review Dr Reddy's biologics license application for Orencia biosimilar DRL_AB Swati Bharadwaj Hyderabad: Dr ...

So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches to research breakthroughs, here are the biggest developments to know: ...

The Nobel Prize in Medicine will never be awarded for excellence in the formulation and manufacture of biologic medicines. That’s understandable. Patients who need these medicines deserve the product ...

Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

ICP recognition supports Axio’s mission to modernize biologics development through data-driven, scalable manufacturing ...

Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Gemini™, a ...

Pharma exports register 9.4 pc growth; industry aims for double-digit expansion in 2026–27: Govt ...

In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis ...